Development of migraine nasal spray

Migraine is the 3rd most prevalent illness and one of the most common neurological diseases in the world. It is estimated that around 1.04 billion people worldwide have been diagnosed with migraines. One of the symptoms of migraine is a one-sided pulsating headache with average to severe intensity which is aggravated by physical activity. It is often accompanied by an aversion to light and sound and with nausea or vomiting, lasting from 4 to 72 hours. About 20 million migraine attack occurs every day. Three times more adult women suffer from migraine than adult men. About 10% of the children between ages 5-15 suffer from the disease. About 50% of women with migraine have more than one attack during a month. In addition to disability, migraine increases the risk of other mental and physical problems. It imposes huge financial and psychological costs on families, companies, and countries. The average health costs of a family with a migraine patient are 70% more than those of a family without such a member.

 

As someone who has suffered from migraines for years, MIM Pharma knew firsthand the debilitating effects we can have on a person’s life. We were determined to develop a solution that could provide fast and effective relief for those who experience migraines.

Design like the following instead:

Our team of top researchers and medical experts explored the underlying causes of migraines and developed a formula based on natural ingredients that would target them directly. After years of research and development, we finally succeeded in creating a breakthrough solution that could provide rapid relief from even the most severe migraine symptoms.

 

 

But our researchers didn’t stop there. We knew that simply creating a solution wasn’t enough – we wanted to make it accessible to those who needed it most. So we work tirelessly to bring our migraine solution to market, ensuring that it is widely available and affordable for those who needed it.

 

 

We want to help countless people to reclaim their lives from the grip of migraines, allowing them to enjoy the things they love without fear of debilitating pain and discomfort. And MIM Pharma continues to innovate, always striving to find new and better ways to help those who suffer from migraines to live happier, healthier lives.

 

 

MIM Pharma’s migraine nasal spray has passed all the requirements and clinical trials that were performed based on the International Headache Society (IHS) guidelines on 500 patients with remarkable results.